UPDATE : Wednesday, June 19, 2019
상단여백
Gilead, Yuhan to co-promote Biktarvy
Yuhan Corp. said Friday that it has signed an agreement with Gilead Science...
by Lee Han-soo  |  2019-03-08 15:32
라인
Roche Korea’s combo therapy gets nod as 1st-line lung cancer therapy
Roche Korea said Friday that its combination therapy -- Tecentriq and Alece...
by Lee Han-soo  |  2019-03-08 14:38
라인
Sanofi Genzyme’s Gaucher disease treatment gets more insurance benefit
Sanofi Genzyme Korea, a subsidiary of Sanofi, said Thursday that the Minist...
by Lee Han-soo  |  2019-03-07 16:22
라인
Daewoong marks record-high sales in 2018
Daewoong Pharmaceutical said Wednesday that it recorded sales of 943.5 bill...
by Lee Han-soo  |  2019-03-07 16:01
라인
When will NOAC reversal agents be available in Korea?
Several drugs that reverse the blood thinning effect of non-vitamin K oral ...
by Kim Yun-mi  |  2019-03-07 15:52
라인
Off-label use of sirolimus for pediatric pulmonary vein stenosis banned
The government has banned the off-label use of sirolimus, an immunosuppress...
by Lee Hye-seon  |  2019-03-07 15:10
라인
Amgen’s Xgeva solves adverse effect problems
Amgen’s Xgeva (ingredient: denosumab) has resolved adverse effect issues fo...
by Lee Han-soo  |  2019-03-07 14:25
라인
‘Korean drugmakers can tap US generic market’
Korean pharmaceutical companies would find it better to utilize long-accumu...
by Jeong Sae-im  |  2019-03-07 11:54
라인
Chinese partner to start trials for Genexine’s immunotherapeutic drug candidate
Genexine said Monday that I-Mab Biopharma, a Chinese bio-firm, has administ...
by Lee Han-soo  |  2019-03-06 14:27
라인
Binex, Chongqing Zein to establish joint company
Binex said Wednesday that it has signed an agreement to establish a joint-v...
by Lee Han-soo  |  2019-03-06 13:41
라인
Medytox keeps urging Daewoong to clarify suspicions over BTX’s origin
Medytox continued Tuesday to pressure Daewoong Pharmaceuticals to clarify s...
by Lee Han-soo  |  2019-03-05 16:22
라인
Hanmi’s acute myeloid leukemia wins developmental stage orphan drug status
The Ministry of Food and Drug Safety has granted Hanmi’s HM43239, a treatme...
by Lee Han-soo  |  2019-03-05 15:34
라인
Handok to market Amicus Therapeutics’ Fabry disease treatment
Handok said Tuesday that it has signed a local sales agreement with Amicus ...
by Lee Han-soo  |  2019-03-05 15:11
라인
Lilly Korea to test rheumatoid arthritis drug for hair loss treatment
Lilly Korea is to conduct a clinical trial on rheumatoid arthritis drug Olu...
by Lee Hye-seon  |  2019-03-05 15:10
라인
3rd-generation antiepileptic drug lands on Korea
Briviact(ingredient: brivaracetam), a third-generation antiepileptic treatm...
by Lee Hye-seon  |  2019-03-05 14:42
라인
IVI gets $3.2 million for typhoid conjugate vaccine study in W. Africa
The International Vaccine Institute (IVI) said it has received a $3.2 milli...
by Lee Han-soo  |  2019-03-05 14:41
라인
Hanmi releases P4 clinical trials for anti-hypertension treatment
Hanmi Pharmaceutical said Monday that it has published the results of phase...
by Lee Han-soo  |  2019-03-04 17:01
라인
Regulator expands XGEVA’s indication for use by multiple myeloma patients
Amgen’s XGEVA (denosumab), a treatment for reducing possibilities of skelet...
by Kim Yun-mi  |  2019-03-04 16:02
라인
AbbVie gets positive views for treatment of plaque psoriasis in EU
AbbVie said Monday that the European Medicines Agency's Committee for M...
by Lee Han-soo  |  2019-03-04 15:57
라인
Qurient unveils P2a trial results for atopic dermatitis treatment in US
Qurient said Monday that it has presented the phase 2a clinical trial resul...
by Lee Han-soo  |  2019-03-04 14:16
여백
여백
여백
Back to Top